We report a woman in her 30s with SLE and AIHA who developed parvovirus B19 infection and secondary PRCA. Hemoglobin did not increase significantly after IVIG treatment; her condition improved significantly following the addition of foscarnet, providing a practical treatment option for secondary PRCA.
No takes yet. Share an insight, caveat, or question.
Xing et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: